Drugs
A recent study published in the December 21, 2000, issue of The New England Journal of Medicine has raised alarming concerns about the safety of popular dietary supplements containing Ephedra. Researchers at the University of California, San Francisco (UCSF) have concluded that these products can pose severe health risks, including
Drugs
Novartis Consumer Health U.S. has announced the voluntary withdrawal of its phenylpropanolamine (PPA)-containing cold and allergy products from retail store shelves. This decision comes after the U.S. Food and Drug Administration (FDA) requested that companies "voluntarily discontinue marketing any drug products containing phenylpropanolamine" due to
Drugs
Engineered muscle cells, incorporating ARIAD's ARGENT cell-growth switch, have been shown to selectively proliferate without promoting unwanted growth of other cardiac cells, such as fibroblasts. This breakthrough could lead to the replacement of damaged heart muscle with healthy tissue in patients with coronary artery disease. The use of
Drugs
Researchers at Vasogen Inc. have presented significant findings demonstrating the beneficial effects of VasoCare(TM) immune modulation therapy for the treatment of cardiovascular diseases. A study conducted by Dr. David Courtman, Director of Research at St. Michael's Hospital, University of Toronto, showed that VasoCare(TM) therapy improved blood
Drugs
More than 50 leading biotechnology companies, both public and private, will converge at Techvest LLC's 2nd Annual Tissue Repair, Replacement and Regeneration Conference to network with institutional investors, venture capitalists, and industry professionals. InformedInvestors.com will webcast the event, providing access to the conference for those unable to
Drugs
Researchers at The Immune Response Corp. in California may have developed the ideal candidate HIV-1 vaccine for testing in both primates and humans. The vaccine combines a whole-killed gp120-depleted HIV antigen with immunostimulatory sequences, which stimulated both CD4 and CD8 immune responses in a Lewis rat model. The study suggests
Drugs
Lexicon Genetics, a leader in defining the functions of genes for drug discovery, has granted a non-exclusive sublicense to Eli Lilly and Company, allowing the latter to use certain aspects of Lexicon's gene-targeting technology in its internal drug discovery and target validation programs. This collaboration is the latest
Drugs
Synaptic Pharmaceutical Corp., a biotechnology company, has made a groundbreaking discovery of a gene and corresponding neuroreceptor that holds significant promise as a new drug target for treating depression. In cell-based and animal studies, the company's researchers have identified a G-protein-coupled receptor (GPCR) that shows potential in producing
Drugs
Standard & Poor's will be making several changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 Indices on November 1, 2000. Key changes include the addition of NiSource Inc. to the S&P 500 Index, Dycom Industries to
Drugs
CEL-SCI Corporation, a developer of Cancer Immuno-Therapy Products, has announced that it has sent a letter to Dr. Bobba Venkatadri, CEO of Molecular Biosystems, Inc. (MBI), stating its intention to acquire MBI at a price of $0.76 per share. This offer represents a significant premium over the price offered
Drugs
Biotechnology entrepreneur Chris Evans is reportedly poised to make a bold move on several UK biotech companies that have faced recent setbacks, including Scotia Holdings, Cantab Pharmaceuticals, Vernalis, and British Biotech. Evans' Merlin Biosciences has recently raised a £150m fund, giving it the resources to acquire assets from struggling
Drugs
The United States Supreme Court let stand a federal appeals court ruling, allowing Abbott Laboratories' Ross Products Division to continue using the claim "1st Choice of Doctors" in advertising its Similac infant formula, a decision that has significant implications for the infant formula market. The ruling follows
